| Literature DB >> 25988580 |
Qi-Jun Wu1,2,3, Gong Yang4, Wei Zheng4, Hong-Lan Li1,2, Jing Gao1,2, Jing Wang1,2, Yu-Tang Gao1,2, Xiao-Ou Shu4, Yong-Bing Xiang1,2.
Abstract
No study to date has prospectively evaluated the association between pre-diagnostic cruciferous vegetables intake and lung cancer survival among women. This analysis included 547 incident lung cancer cases identified from the Shanghai Women's Health Study (SWHS) during the follow-up period of 1997-2011. Dietary intake was assessed for all SWHS participants at enrollment and reassessed 2-3 years later. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) with adjustment for potential confounders. Of the 547 lung cancer patients, 412 patients died during the follow-up. A total of 393 (95.4%) deaths from lung cancer were documented with median survival time of 10.3 months (interquartile range, 3.6-21.1 months). High cruciferous vegetables intake was significantly associated with improved lung cancer-specific survival after adjusting for all nonclinical prognostic factors (n = 547, HR = 0.69; 95%CI = 0.49-0.95; P trend = 0.02) for the highest versus lowest quartile. A slightly stronger association of cruciferous vegetables intake with lung cancer-specific survival was observed in analyses restricted to patients with known clinical prognostic factors (n = 331, HR = 0.63; 95%CI = 0.41-0.97; P trend = 0.03) or never smokers (n = 308, HR = 0.58; 95%CI = 0.37-0.91; P trend = 0.02). In conclusion, pre-diagnostic cruciferous vegetables intake is associated with better survival of lung cancer in Chinese women.Entities:
Mesh:
Year: 2015 PMID: 25988580 PMCID: PMC4650798 DOI: 10.1038/srep10306
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographic and selected lifestyle characteristics and clinical predictors of lung cancer patients by quartile for pre-diagnostic cruciferous vegetables intake: the Shanghai Women’s Health Study, 1997 to 2011
| No. of Events | 109 | 102 | 102 | 99 | |
| Age at diagnosis (years), Mean (SD) | 67.0 (9.0) | 66.4 (9.1) | 66.4 (9.4) | 66.9 (8.6) | 0.90 |
| Time interval between first FFQ and cancer diagnosis (years) | 7.2 (0.3) | 7.6 (0.3) | 7.6 (0.3) | 7.3 (0.3) | 0.54 |
| Body mass index (kg/m2) | 23.9 (0.3) | 24.1 (0.3) | 24.5 (0.3) | 24.6 (0.3) | < 0.01 |
| Physical activity (MET hour/week) | 103.8 (4.1) | 112.9 (4.0) | 107.2 (4.0) | 114.4 (4.0) | 0.29 |
| Total energy intake (kcal/day) | 1431.8 (29.9) | 1545.1 (29.8) | 1642.1 (29.8) | 1773.2 (29.8) | < 0.01 |
| Fruit intake (g/day) | 167.1 (11.8) | 201.3 (11.7) | 240.2 (11.7) | 283.7 (11.7) | < 0.01 |
| Non-cruciferous vegetables intake (g/day) | 111.5 (9.2) | 161.1 (9.2) | 202.7 (9.2) | 286.1 (9.2) | < 0.01 |
| Soy food intake (g/day) | 110.7 (9.5) | 136.6 (9.5) | 162.1 (9.5) | 182.2 (9.5) | < 0.01 |
| Education level | 0.44 | ||||
| Elementary school or less | 66 (47.2) | 48 (35.5) | 55 (40.7) | 60 (43.6) | |
| Middle school | 30 (22.7) | 38 (27.4) | 33 (23.6) | 33 (24.2) | |
| High school | 22 (16.4) | 31 (22.3) | 38 (27.8) | 21 (15.4) | |
| College or above | 18 (13.6) | 20 (14.8) | 11 (7.9) | 23 (16.8) | |
| Cigarette smoking | 18 (13.2) | 13 (9.7) | 5 (3.7) | 12 (8.7) | 0.06 |
| Tea drinking | 42 (31.6) | 33 (24.0) | 41 (29.4) | 48 (35.1) | 0.24 |
| History of lung disease | 32 (23.9) | 29 (21.1) | 24 (17.5) | 25 (18.3) | 0.60 |
| Passive smoking | 31 (25.1) | 36 (29.6) | 28 (21.6) | 32 (25.6) | 0.54 |
| Tumor stage | 0.31 | ||||
| I and II | 10 (7.5) | 8 (5.8) | 15 (10.8) | 12 (8.8) | |
| III | 25 (18.7) | 16 (11.7) | 24 (17.2) | 23 (16.8) | |
| IV | 49 (35.6) | 56 (40.4) | 48 (35.5) | 45 (32.9) | |
| Unknown | 52 (38.3) | 57 (42.1) | 50 (36.5) | 57 (41.5) | |
| Chemotherapy | 0.73 | ||||
| Yes | 78 (57.7) | 86 (63.0) | 84 (61.2) | 87 (63.7) | |
| No | 58 (42.3) | 51 (37.0) | 53 (38.8) | 50 (36.3) | |
| Surgery | 0.46 | ||||
| Yes | 40 (30.0) | 53 (38.9) | 49 (35.1) | 48 (35.2) | |
| No | 96 (70.0) | 84 (61.1) | 88 (64.9) | 89 (64.8) | |
| Radiotherapy | 0.97 | ||||
| Yes | 25 (18.8) | 25 (18.1) | 23 (16.5) | 24 (17.6) | |
| No | 111 (81.2) | 112 (81.9) | 114 (83.5) | 113 (82.4) | |
| Histological type | 0.09 | ||||
| Nonadenocaricinoma | 23 (34.5) | 17 (22.0) | 16 (16.2) | 24 (27.0) | |
| Adenocarcinoma | 43 (64.8) | 64 (78.7) | 73 (84.5) | 65 (72.4) | |
NOTE. For all characteristics except age at diagnosis, means (standard errors), or percentages were adjusted for age at baseline. Pre-diagnostic cruciferous vegetables intake was estimated by averaging the data from the first FFQ and the second FFQ surveys. For patients who provided no second FFQ data or reported having chronic diseases (e.g., diabetes, cardiovascular) or lung cancer diagnosed between the two FFQs, only the intake estimates from the first FFQ were used. Abbreviations: FFQ, food frequency questionnaire.
†Kruskal-Wallis test
‡Frequency; χ2 test
§Lung disease including asthma, chronic bronchitis, and tuberculosis.
¶Among non-smoking patients (n = 499).
*Among patients with available data on histological type (n = 325).
Demographic and clinical characteristics and lung cancer specific survival among lung cancer patients with clinical information: the Shanghai Women’s Health Study, 1997 to 2011
| Age at diagnosis (year) | |||
| ≤60 | 85/58 | 1.0 | (Ref) |
| 60-70 | 120/91 | 1.14 | (0.81-1.61) |
| > 70 | 126/101 | 1.42 | (1.00-2.03) |
| Overweight/obese (BMI ≥25 kg/m2) | |||
| No | 201/148 | 1.0 | (Ref) |
| Yes | 130/102 | 1.03 | (0.79-1.33) |
| Education (High school and above) | |||
| No | 288/223 | 1.0 | (Ref) |
| Yes | 43/27 | 0.74 | (0.49-1.11) |
| Cigarette smoking | |||
| No | 308/231 | 1.0 | (Ref) |
| Yes | 23/19 | 2.01 | (1.23-3.30) |
| Tea drinking | |||
| No | 225/177 | 1.0 | (Ref) |
| Yes | 106/73 | 0.63 | (0.47-0.83) |
| Tumor stage | |||
| I and II | 45/17 | 1.0 | (Ref) |
| III | 88/73 | 3.22 | (1.84-5.64) |
| IV | 198/160 | 5.13 | (2.84-9.29) |
| Chemotherapy | |||
| No | 102/71 | 1.0 | (Ref) |
| Yes | 229/179 | 0.76 | (0.57-1.02) |
| Surgery | |||
| No | 216/180 | 1.0 | (Ref) |
| Yes | 115/70 | 0.76 | (0.54-1.07) |
| Radiotherapy | |||
| No | 263/196 | 1.0 | (Ref) |
| Yes | 68/54 | 0.84 | (0.62-1.16) |
| Histological type | |||
| Nonadenocaricinoma | 45/34 | 1.0 | (Ref) |
| Adenocarcinoma | 171/116 | 0.94 | (0.61-1.43) |
†HRs (95% CIs) for lung cancer specific survival was estimated by using multivariable proportional hazards models, mutually adjusted for all other variables listed in the table except for pathologic type.
‡Data on the histological type of lung cancer were missing for 115 patients.
NOTE. Analyses were restricted to patients with lung cancer who had data available on both nonclinical and clinical variables (n = 331). Abbreviations: BMI, body mass index; CI, confidence interval; HR, hazards ratio.
HR for lung cancer-specific survival among lung cancer patients according to pre-diagnostic cruciferous vegetables intake: the Shanghai Women’s Health Study, 1997 to 2011
| Q1 | Q2 | Q3 | Q4 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Range of intake (Median) | <53.2 (37.6) | 53.2-83.4 (65.4) | 83.4-118.7 (97.9) | ≥118.7 (150.1) | |||||
| No./Events | 136/100 | 137/100 | 137/99 | 137/94 | |||||
| Model 1 | 1.00 | (Ref) | 0.97 | 0.73-1.29 | 0.88 | 0.66-1.18 | 0.72 | 0.53-0.97 | 0.02 |
| Model 2 | 1.00 | (Ref) | 0.94 | 0.71-1.26 | 0.88 | 0.65-1.19 | 0.69 | 0.49-0.95 | 0.02 |
| Range of intake (Median) | <52.1 (34.7) | 52.1-84.4 (64.7) | 84.4-116.8 (98.6) | ≥116.8 (148.4) | |||||
| No./Events | 82/60 | 83/66 | 83/65 | 83/59 | |||||
| Model 1 | 1.00 | (Ref) | 1.19 | 0.82-1.72 | 0.91 | 0.63-1.31 | 0.69 | 0.47-1.01 | 0.01 |
| Model 3 | 1.00 | (Ref) | 0.95 | 0.65-1.39 | 0.91 | 0.62-1.34 | 0.63 | 0.41-0.97 | 0.03 |
| Range of intake (Median) | <53.1 (37.3) | 53.1-85.5 (65.1) | 85.5-116.4 (99.1) | ≥116.4 (149.1) | |||||
| No./Events | 77/56 | 77/62 | 77/59 | 77/54 | |||||
| Model 1 | 1.00 | (Ref) | 1.21 | 0.82-1.77 | 0.89 | 0.61-1.31 | 0.67 | 0.45-1.00 | 0.01 |
| Model 4 | 1.00 | (Ref) | 0.90 | 0.61-1.34 | 0.88 | 0.59-1.33 | 0.58 | 0.37-0.91 | 0.02 |
NOTE. Pre-diagnostic cruciferous vegetables intake was estimated by averaging the data from the first FFQ and the second FFQ surveys. For patients who provided no second FFQ data or reported having chronic diseases (e.g., diabetes, cardiovascular) or lung cancer diagnosed between the two FFQs, only the intake estimates from the first FFQ were used.Abbreviations: CI, confidence interval; HR, hazards ratio.
*P for trend; tests calculated by entering stratum-specific median values for cruciferous vegetables intake as continuous variables in Cox proportional hazards models.
†HRs (95% CIs) for lung cancer-specific survival was estimated by using multivariable proportional hazards models which were stratified on birth year and adjusted for adjusted for age at diagnosis and total energy intake.
‡Same as Model 1 and further adjusted for body mass index, tea drinking, cigarette smoking, intakes of fruit and non-cruciferous vegetables.
§Same as Model 2 and further adjusted for tumor stage, surgery, radiotherapy, and chemotherapy.
¶Same as Model 3 but without adjusting for cigarette smoking.
Figure 1Multivariable-adjusted lung cancer-specific survival curves of patients (n = 547) with lung cancer by pre-diagnostic intake of cruciferous vegetables, estimated from a stratified proportional hazards model (stratified on birth year and adjusted for age at diagnosis, body mass index, tea drinking, cigarette smoking, intakes of energy, fruit and non-cruciferous vegetables) by using a direct adjustment method36. The green line indicates the Q1 (lowest) of intake, the blue line indicates the Q2, the gold line indicates the Q3, and the red line indicates the Q4 of intake (highest).